Personal profile
Education/Academic qualification
PhD, Cellular and molecular biology , University of Reims Champagne-Ardenne, Faculty of Pharmacy
Award Date: 11 Dec 2004
Master, Biochemistry, molecular and cellular Biology , University of Reims Champagne-Ardenne, Faculty of Exact and Natural Sciences
Award Date: 9 Jul 2001
Bachelor, Biological sciences (biochemistry specialty), University of Reims Champagne-Ardenne (URCA), Faculty of Exact and Natural Sciences
Award Date: 5 Jul 1999
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
HDAC6 inhibitors sensitize resistant t(11;14) multiple myeloma cells to a combination of bortezomib and BH3 mimetics
Florean, C., Lernoux, M., Lorant, A., Losson, H., Bormans, G., Schnekenburger, M. & Diederich, M., 1 Mar 2025, In: Haematologica. 110, 3, p. 784-790 7 p.Research output: Contribution to journal › Letter › peer-review
Open Access1 Citation (Scopus) -
Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia
Yang, H., Li, V., Park, S. J., Cheon, S. W., Lorant, A., Mazumder, A., Lee, J. Y., Orlikova-Boyer, B., Cerella, C., Christov, C., Kirsch, G., Olberg, D. E., Bormans, G., Kang, H. J., Han, B. W., Schnekenburger, M. & Diederich, M., 16 Jul 2025, In: Clinical Epigenetics. 17, 1, 27 p., 125.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Preparation and pharmacological characterization of the enantiomers of the anticancer agent R/S-N-3-cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea: Identification of the R-enantiomer as the active eutomer
Schnekenburger, M., Goffin, E., Schoumacher, M., Tumanov, N., Mouithys-Mickalad, A., de Tullio, P., Wouters, J., Lebrun, P., Diederich, M. & Pirotte, B., Apr 2025, In: European Journal of Medicinal Chemistry Reports. 13, 100244.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus) -
Tetrahydrobenzimidazole TMQ0153 targets OPA1 and restores drug sensitivity in AML via ROS-induced mitochondrial metabolic reprogramming
Park, S. J., Cerella, C., Kang, J. M., Byun, J., Kum, D., Orlikova-Boyer, B., Lorant, A., Schnekenburger, M., Al-Mourabit, A., Christov, C., Lee, J., Han, B. W. & Diederich, M., 7 Apr 2025, In: Journal of Experimental and Clinical Cancer Research. 44, 1, 28 p., 114.Research output: Contribution to journal › Article › Research › peer-review
Open Access8 Citations (Scopus) -
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia
Pottier, A., Park, S., Lee, Y., Liccardo, F., Yang, H., Park, J., Lorant, A., Schnekenburger, M., Brusa, D., Li, V., Valente, S., Mai, A., Skuli, S. J., Carroll, M., Boettcher, S., Sarry, J. E., Cerella, C., Morceau, F. & Diederich, M., 28 Nov 2025, In: Cancer Letters. 633, 218011.Research output: Contribution to journal › Article › Research › peer-review
Open Access1 Citation (Scopus)